GlassScriptPhysician profile
Andrea Eden
NPI 1245456821
$365.72
in general payments reported to CMS, 2019-2025
18 companies · $366 in 2025
The $366 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $366.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $366.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $365.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $37.79 | 2025 | Wegovy, Ozempic, Rybelsus |
| Bayer Healthcare Pharmaceuticals INC. | $32.84 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $28.23 | 2025 | Trintellix |
| Lilly USA, LLC | $22.61 | 2025 | Mounjaro |
| Corcept Therapeutics | $22.20 | 2025 | Korlym |
| Abbott Laboratories | $20.75 | 2025 | Freestyle Libre 3 |
| Pfizer INC. | $19.70 | 2025 | |
| Insulet Corporation | $19.13 | 2025 | Omnipod |
| Abbvie INC. | $18.91 | 2025 | |
| Sumitomo Pharma America, INC. | $18.39 | 2025 | Gemtesa |
| Dynavax Technologies Corporation | $17.61 | 2025 | Heplisav-B |
| Lundbeck LLC | $17.42 | 2025 | Vyepti |
| Astrazeneca Pharmaceuticals LP | $16.02 | 2025 | Breztri |
| Otsuka America Pharmaceutical, INC. | $15.68 | 2025 | Rexulti |
| Merck Sharp & Dohme LLC | $15.30 | 2025 | Gardasil 9, Capvaxive |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $14.86 | 2025 | Arexvy, Shingrix |
| Exact Sciences Corporation | $14.71 | 2025 | |
| Avvisto Therapeutics, LLC | $13.57 | 2025 | Cycloset |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrea Eden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.